Government may revise compensation formula for 'faulty' Johnson & Johnson hip implant patients

The development follows opposition to the approved formula by several patients as well as J&J in the last month.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2SiWdxT
via IFTTT